US5541287A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pretargeting methods and compounds
Assignee: Aletheon Pharmaceuticals Inc
•
Filing: 1994-11-22
•
Granted: 1996-07-30
•
Expires: 2014-11-22
Abstract
Abstract Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin, as well as related compounds, are described. Articles of manufacture useful in pretargeting methods are also discussed.
Inventors
- 👤 Eric K. Yau
- 👤 Louis J. Theodore
- 👤 Linda M. Gustavson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:26
CPC Classifications
B; B82; B82Y; B82Y5/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6891; A61K47/6893; A61K47/54; A61K47/555; A61K47/557; A61K47/62; A61K47/66; A61K47/665; A61K47/6835; A61K47/6887; A61K47/6897; A61K47/6898; A61K51/00; A61K51/02; A61K51/04; A61K51/0497; A61K51/12; A61K51/1268; C; C07; C07K; C07K1/00; C07K1/107; C07K1/1072; C07K1/1077; C07K5/00; C07K5/04; C07K5/12; C07K5/126; A61K2121/00; A61K2123/00
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
73 words
A method of producing nitro-benzyl-DOTA via the select N-alkylation of a compound having a trifluoroacetamide group with an iodoacetyl derivative in the presence of base comprising: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent such that said carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group; and allowing said acyclic tripeptide to cyclize to form a cyclic tripeptide.
Claim 2
Independent Claim
73 words
A method of producing nitro-benzyl-DOTA via the select N-alkylation of a compound having a trifluoroacetamide group with an iodoacetyl derivative in the presence of base comprising: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent such that said carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group; and allowing said acyclic tripeptide to cyclize to form a cyclic tripeptide.
Claim 3
Dependent Claim
11 words
The method of claim 1, wherein said trifluoroacetamide group is N-BOC-glycyltrifluoroacetylethylenediamine.
Claim 4
Dependent Claim
13 words
The method of claim 1, wherein said iodoacetyl derivative is iodoacetyl-p-nitrophenylalanine t-butyl ester.
Claim 5
Dependent Claim
11 words
The method of claim 1, wherein said acyclic tripeptide is glycyl-N-ethylenediamino-N'-tri-fluoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine.
Claim 6
Dependent Claim
17 words
The method of claim 1, wherein said cyclic tripeptide is 2-(p-nitrobenzyl)-3, 6, 9, 12-trioxy-10-trifluoroacetyl-1, 4, 7, 10-tetraazacyclododecane.
Claim 7
Dependent Claim
19 words
The method of claim 1, wherein cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexa-fluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA).
Claim 8
Independent Claim
113 words
A method for the synthesis of 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane which comprises: (i) reacting ethylenediamine with N-BOC-p-nitrophenylglycinate to produce ##STR49## (ii) reacting the product of (i) with CF 3 CO 3 Et and methanol to produce ##STR50## (iii) reacting the product of (ii) with ##STR51## in the presence of NaH and THF to produce ##STR52## (iv) reacting the product of (iii) with THF and CH 2 Cl 2 to produce ##STR53## (v) reacting the product of (iv) with benzotriazolyl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP), DMF and DIEA to produce ##STR54## (vi) reacting the product of (v) with NH 4 OH and methanol to produce ##STR55## (vii) reacting the product of (vi) with BH 3 and THF to produce 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane.
Claim 9
Independent Claim
113 words
A method for the synthesis of 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane which comprises: (i) reacting ethylenediamine with N-BOC-p-nitrophenylglycinate to produce ##STR49## (ii) reacting the product of (i) with CF 3 CO 3 Et and methanol to produce ##STR50## (iii) reacting the product of (ii) with ##STR51## in the presence of NaH and THF to produce ##STR52## (iv) reacting the product of (iii) with THF and CH 2 Cl 2 to produce ##STR53## (v) reacting the product of (iv) with benzotriazolyl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP), DMF and DIEA to produce ##STR54## (vi) reacting the product of (v) with NH 4 OH and methanol to produce ##STR55## (vii) reacting the product of (vi) with BH 3 and THF to produce 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane.
Claim 10
Dependent Claim
21 words
The method of claim 7, wherein said α-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane obtained in step (vii) is converted to 2-(p-nitrobenzyl)-DOTA by reaction with bromoacetic acid.
Claim 11
Independent Claim
97 words
A method of producing the product ##STR56## comprising the following steps: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifiuoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and wherein cyclization is effected with benzyltriazolyloxy-tris(dimaethylamino)phosphoride hexafiuoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR57## reacting the previous cyclic compotmd in the presence of ammonium hydroxide and methanol to produce said product.
Claim 12
Independent Claim
97 words
A method of producing the product ##STR56## comprising the following steps: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifiuoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and wherein cyclization is effected with benzyltriazolyloxy-tris(dimaethylamino)phosphoride hexafiuoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR57## reacting the previous cyclic compotmd in the presence of ammonium hydroxide and methanol to produce said product.
Claim 13
Independent Claim
113 words
A method of producing the following product: ##STR58## comprising the following steps: treating an acyclic peptide having an N-tenninal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic peptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifluoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexafluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR59## reacting the previous cyclic coinpound in the presence of ammonium hydroxide and methanol to produce the following compound: ##STR60## and reacting the previous compound with BF 3 and THF to produce said product.
Claim 14
Independent Claim
113 words
A method of producing the following product: ##STR58## comprising the following steps: treating an acyclic peptide having an N-tenninal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic peptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifluoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexafluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR59## reacting the previous cyclic coinpound in the presence of ammonium hydroxide and methanol to produce the following compound: ##STR60## and reacting the previous compound with BF 3 and THF to produce said product.
References Cited (Backward Citations)
US4687667A
Cited
US4647447A
Cited
US4898951A
Cited
US4867973A
Cited
US4639365A
Cited
US4833251A
Cited
US5225353A
Cited
US4863713A
Cited
EP0251494A2
Cited
US5246692A
Cited
US5256395A
Cited
US4775745A
Cited
WO1988008422A1
Cited
EP0327365A2
Cited
WO1989011475A1
Cited
US4923985A
Cited
US4895955A
Cited
US5141966A
Cited
EP0451824A2
Cited
EP0496074A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-07-30 | 2000-01-29 | 2000-07-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-07-30 | 2004-01-29 | 2004-07-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-07-30 | 2008-01-29 | 2008-07-30 | $7700.00 | Window Closed / Lapsed |